8-K
ZRCN Inc. (ZRCN)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date of Report (date of earliest event reported): August 20, 2024
ZRCNInc.
(Exact name of Registrant as specified in its charter)
| Delaware | 000-56380 | 83-2756695 |
|---|---|---|
| (State<br> or other jurisdiction<br><br> <br>of<br> incorporation) | (Commission<br><br> <br>File<br> Number) | (I.R.S.<br> Employer<br><br> <br>Identification<br> No.) |
1580 Dell Avenue, Campbell, CA. ### 95008.
(Address of principal executive offices and zip code)
(408)963-4550
Registrant’s
telephone number, including area code:
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ☐ | Written<br> communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|---|---|
| ☐ | Soliciting<br> material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement<br> communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement<br> communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered under Section 12(b) of the Exchange Act: None
| Title<br> of each class | Trading<br> Symbol(s) | Name<br> of each exchange on which registered |
|---|---|---|
| N/A | N/A | N/A |
Securities registered under Section 12(g) of the Exchange Act:
Common Stock, par value $0.0001 per share
(Title of class)
Item5.02 - Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangementsof Certain Officers.
On August 14, 2024, Ron Bourque, a Director of ZRCN Inc. (“ZRCN” or the “Company”), and of Zircon Corporation (“Zircon”), a wholly owned subsidiary of ZRCN, announced his intention to retire as a Director of the Company and of Zircon effective August 14, 2024. Mr. Bourque will remain available to management under the terms of his arrangement with the Company and Zircon, to provide transition assistance and support to the Company and Zircon, and to Joseph R. Bronson, who will succeed Mr. Bourque as Director of the Company and Zircon as described below.
On August 14, 2024, ZRCN Inc. (“ZRCN” or the “Company”), and of Zircon Corporation (“Zircon”), a wholly owned subsidiary of ZRCN, appointed Joseph R. Bronson as a Director of the Company Zircon, effective immediately. Mr. Bronson does not have any family relationship with any director, executive officer or person nominated or chosen by the Company and by Zircon to become a director or executive officer of either entity. There is no understanding or arrangement between Mr. Bronson and any other person pursuant to which he was selected as a director of the Company or of Zircon. Other than the directors agreement described below, there are no transactions in which Mr. Bronson has an interest requiring disclosure under Item 404(a) of Regulation S-K.
Mr. Bronson has served as Chief Executive Officer and Principal of The Bronson Group, LLC., a business advisory group focused on operational and financial consulting since 2012. He also is an advisor and supervisory board member of Solayer, an equipment company based in Germany and China in the advanced optical applications area. He has been an adviser to AMEC, a semiconductor equipment company, based in Shanghai, China since 2008. From 2016 to 2021 Mr. Bronson was a Managing Director and Strategic Advisor to Cowen, a New York City based investment bank. In February 2024, he became an advisor to FMC (Ferro-electric Memory Corporation), a company involved in the design and fabrication of advanced memory semiconductor chips.
Mr. Bronson currently serves on the board of PDF Solutions, Inc. (NASDAQ: PDFS), a leading provider of comprehensive data solutions for the semiconductor ecosystem, as the lead Director. Mr. Bronson joined the board of Graph Audio in August 2021, a development stage enterprise engaged in the development of graphene materials with focus on audio equipment. Mr. Bronson currently serves as a Regent at Santa Clara University and Loyola Marymount University. He had been a member of the Board of Trustees of Fairfield University from 2009 until February 2021. He is a past Chair of the Board of Trustees of Bellarmine Preparatory School in San Jose, California and became an Emeritus Director in 2023 after 20 years of service. He is also the Chair of the Advisory Board of the Leavey School of Business at Santa Clara University. Mr. Bronson is a certified public accountant and holds a Bachelor of Science degree in accounting from Fairfield University and a Master of Business Administration from the University of Connecticut.
The Company has also entered into a Board of Director Agreement (“Director Agreement”) with Mr. Bronson in connection with his appointment. Under the terms of the Director Agreement, Mr. Bronson will receive a flat fixed cash fee of seven thousand two hundred dollars ($7,200) per quarter and will be granted an option to purchase forty-eight thousand (48,000) shares of the Company’s common stock, that will vest one (1) year from the date of grant.
The foregoing summary of the terms and conditions of the Director Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Director Agreement attached hereto as Exhibits 10.1which is incorporated herein by reference.
| Exhibit No. | Description |
|---|---|
| 10.1 | Board of Director Agreement, dated August 14, 2024, by and between ZRCN Inc . and Joseph Bronson |
| 104 | Cover<br> Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| ZRCN<br> Inc. | ||
|---|---|---|
| Date:<br> August 20, 2024 | By: | /s/ Jeff Parsons |
| Jeff<br> Parsons | ||
| Chief<br> Financial Officer |
Exhibit10.1
BOARD OF DIRECTOR AGREEMENT
THIS AGREEMENT is made and entered into effective as of the 14th day of August, 2024 (the “Effective Date”), by and between ZRCN Inc., a Delaware corporation (“Company”), and Joseph Bronson, an individual (“Director”).
1. Term. This Agreement shall commence from the Effective Date and shall continue thereafter until the Director’s resignation, removal or failure to stand for re-election for any reason.
2. Position and Responsibilities.
(a) Position. Company hereby retains Director to serve as a member of the Board of Directors. Director shall perform such duties and responsibilities as are normally related to such position in accordance with Company’s Certificate of Incorporation, as amended (the “Charter”), bylaws, as amended (the “Bylaws”) and applicable law, including those services described on Exhibit A, (the “Services”), and Director hereby agrees to use his best efforts to provide the Services. Director shall not allow any other person or entity to perform any of the Services for or instead of Director. Director shall comply with the statutes, rules, regulations, and orders of any governmental or quasi-governmental authority, which are applicable to the performance of the Services, and Company’s rules, regulations, and practices as they may from time to time be adopted or modified.
(b) Other Activities. Director may be employed by another company, may serve on other Boards of Directors or Advisory Boards, and may engage in any other business activity (whether or not pursued for pecuniary advantage), as long as such outside activities do not violate Director’s obligations under this Agreement or Director’s fiduciary obligations to the shareholders. The ownership of less than a 5% interest in an entity, by itself, shall not constitute a violation of this duty. Director represents that, to the best of his knowledge, Director has no outstanding agreement or obligation that is in conflict with any of the provisions of this Agreement, and Director agrees to use his best efforts to avoid or minimize any such conflict and agrees not to enter into any agreement or obligation that could create such a conflict, without the approval of a majority of the Board of Directors. If, at any time, Director is required to make any disclosure or take any action that may conflict with any of the provisions of this Agreement, Director will promptly notify the Chairman of the Board of such obligation, prior to making such disclosure or taking such action.
(c) No Conflict. Except as set forth in Section 2(b, Director will not engage in any activity that creates an actual conflict of interest with Company, regardless of whether such activity is prohibited by Company’s conflict of interest guidelines or this Agreement, and Director agrees to notify the Board of Directors before engaging in any activity that creates a potential conflict of interest with Company. Specifically and except as set forth in Section 2(b) of this Agreement, Director shall not engage in any activity that is in direct competition with the Company or serve in any capacity (including, but not limited to, as an employee, consultant, advisor or director) in any company or entity that competes directly with the Company, as reasonably determined by a majority of Company’s disinterested board members, without the approval of the Chairman of the Board.
3. Compensation and Benefits.
(a) Director’s Fee. In consideration of the Services to be rendered under this Agreement, Company shall pay a non-employee director’s fee of Seven Thousand Two Hundred Dollars ($7,200) per calendar quarter, payable each such quarter during the term hereof in arrears, pro-rated for any period of less than a calendar quarter, with the first payment due September 30, 2024. The Company shall also award Director a non-employee, non-qualified stock option to purchase Forty-Eight Thousand (48,000) shares of Company common stock (the “Equity Grant”) subject to and in accordance with the terms of the Company’s 2024 Omnibus Equity Incentive Plan (the “Plan”) and Director’s entering into a stock option agreement with Company. The effective date of the Equity Grant shall be the date the Company’s board of directors approves said Equity Grant. The date of vesting shall be one business day before the expiration or termination of this Agreement, subject to the continued service of Director during the term of this Agreement. In the event (i) of a merger, change in control or sale of Company or (ii) Director either is terminated as a board member or is not reelected, where the Director has not engaged in conduct during his tenure on the board which would constitute “cause” for such termination, as determined by a majority vote of the disinterested board members, the shares immediately shall become fully vested. The removal of Director, by itself, shall not affect the vesting schedule.
(b) Benefits. Director shall not be eligible to participate in any benefits made generally available by Company to its senior executives, and Director shall not be entitled to any paid vacation leave.
(c) Expenses. The Company shall reimburse the Director for pre-approved reasonable business-related expenses incurred in good faith in connection with the performance of the Director’s duties for the Company. Such reimbursement shall be made by the Company upon submission by the Director of a signed statement itemizing the expenses incurred, which shall be accompanied by sufficient documentation to support the expenditures.
(d) Indemnification. Company will indemnify and defend Director against any liability incurred in the performance of the Services to the fullest extent authorized in Company’s Charter, Bylaws and applicable law. Company has purchased Director’s and Officer’s liability insurance, and Director shall be entitled to the protection of any insurance policies the Company maintains for the benefit of its Directors and Officers against all costs, charges and expenses in connection with any action, suit or proceeding to which he may be made a party by reason of his affiliation with Company, its subsidiaries, or affiliates, subject to any limitations included in the subject insurance policy.
4. Termination.
(a) Right to Terminate. At any time, Director may be removed or resign as a Director as provided in Charter, Bylaws and applicable law.
(b) Effect of Termination. Upon termination of Director’s status, this Agreement will terminate, along with any modifications to which both parties mutually agree. Except as provided herein, the Company shall pay to Director all compensation to which Director is entitled up through the month of termination, and thereafter, all of the Company’s obligations under this Agreement shall cease, except as provided in Sections 3(c), 3(d), and 5.
5. Termination Obligations.
(a) Director agrees that all property, including, without limitation, all equipment, tangible proprietary information, documents, records, notes, contracts, and computer-generated materials provided to or prepared by Director, incident to his Services, belong to Company and shall be promptly returned at the request of Company.
(b) Upon termination of this Agreement, Director shall be deemed to have resigned from all offices then held with Company by virtue of his position. Director agrees that following any termination of this Agreement, he shall cooperate with Company in the winding up or transferring to other directors of any pending work and shall also cooperate with Company (to the extent allowed by law, and at Company’s expense) in the defense of any action brought by any third party against Company that relates to the Services.
(c) The Company and Director agree that their obligations under this Section, as well as Sections 3(d), 4(b), and 7, shall survive the termination of this Agreement.
6. Nondisclosure Obligations. Director shall maintain in confidence and shall not, directly or indirectly, disclose or use, either during or after the term of this Agreement, any Proprietary Information (as defined below), confidential information, or trade secrets belonging to Company, whether or not it is in written or permanent form, except to the extent necessary to perform the Services, as required by a lawful government order or subpoena, or as authorized in writing by Company. These nondisclosure obligations also apply to Proprietary Information belonging to customers and suppliers of Company, and other third parties, learned by Director as a result of performing the Services. “Proprietary Information” means all information pertaining in any manner to the business of Company, unless (i) the information is or becomes publicly known through lawful means; (ii) the information was part of Director’s general knowledge prior to his or her relationship with Company; or (iii) the information is disclosed to Director without restriction by a third party who rightfully possesses the information and did not learn of it from Company.
7. Governing Law, Jurisdiction, and Venue. This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware. The parties agree that any suit, action, or proceeding between Director (and his attorneys, successors, and assigns) and Company (and its affiliates, shareholders, directors, officers, employees, members, agents, successors, attorneys, and assigns) relating to the Services or the termination of those Services shall be brought in either the United States District Court for the Northern District of California or in an appropriate California state court and that the parties shall submit to the jurisdiction of such court. The parties irrevocably waive, to the fullest extent permitted by law, any objection the party may have to the laying of venue for any such suit, action or proceeding brought in such court. If any one or more provisions of this Section shall for any reason be held invalid or unenforceable, it is the specific intent of the parties that such provisions shall be modified to the minimum extent necessary to make it or its application valid and enforceable.
8. Entire Agreement. This Agreement is intended to be the final, complete, and exclusive statement of the terms of Director’s relationship solely with respect to his position with Company. This Agreement entirely supersedes any and all previous Agreements between the Director and the Company, and may not be contradicted by evidence of any prior or contemporaneous statements or agreements pertaining to Director’s relationship. Agreements related to Director’s ownership of the Securities are not affected by this Agreement.
9. Amendments; Waivers. This Agreement may not be amended except by a writing signed by Director and by a duly authorized representative of the Company other than Director. Failure to exercise any right under this Agreement shall not constitute a waiver of such right.
10. Assignment. Director agrees that Director will not assign any rights or obligations under this Agreement, with the exception of Director’s ability to assign rights with respect to the Securities. Nothing in this Agreement shall prevent the consolidation, merger or sale of Company or a sale of all or substantially all of its assets.
11. Severability. If any provision of this Agreement shall be held by a court or arbitrator to be invalid, unenforceable, or void, such provision shall be enforced to fullest extent permitted by law, and the remainder of this Agreement shall remain in full force and effect. In the event that the time period or scope of any provision is declared by a court or arbitrator of competent jurisdiction to exceed the maximum time period or scope that such court or arbitrator deems enforceable, then such court or arbitrator shall reduce the time period or scope to the maximum time period or scope permitted by law.
12. Interpretation. This Agreement shall be construed as a whole, according to its fair meaning, and not in favor of or against any party. Captions are used for reference purposes only and should be ignored in the interpretation of the Agreement.
13. Binding Agreement. Each party represents and warrants to the other that the person(s) signing this Agreement below has authority to bind the party to this Agreement and that this Agreement will legally bind both Company and Director. This Agreement will be binding upon and benefit the parties and their heirs, administrators, executors, successors and permitted assigns. To the extent that the practices, policies, or procedures of Company, now or in the future, are inconsistent with the terms of this Agreement, the provisions of this Agreement shall control. Any subsequent change in Director’s duties or compensation will not affect the validity or scope of the remainder of this Agreement.
14. Director Acknowledgment; Non-Disparagement. Director acknowledges Director has had the opportunity to consult legal counsel concerning this Agreement, that Director has read and understands the Agreement, that Director is fully aware of its legal effect, and that Director has entered into it freely based on his own judgement and not on any representations or promises other than those contained in this Agreement. At all times during and after the period in which the Director is a member of the Board and at all times thereafter, the Director shall not either verbally, in writing, electronically or otherwise: (i) make any derogatory or disparaging statements about the Company, any of its affiliates, any of their respective officers, directors, shareholders, employees and agents, or any of the Company’s current or past customers or employees, or (ii) make any public statement or perform or do any other act prejudicial or injurious to the reputation or goodwill of the Company or any of its affiliates or otherwise interfere with the business of the Company or any of its affiliates; provided, however, that nothing in this paragraph shall preclude the Director from complying with all obligations imposed by law or legal compulsion, and provided, further, however, that nothing in this paragraph shall be deemed applicable to any testimony given by the Director in any legal or administrative proceedings
15. Counterparts. This Agreement may be executed in any number of counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.
IN WITNESS WHEREOF, the parties have duly executed this Agreement as of the date set forth below.
| Director | ZRCN<br> Inc. | ||
|---|---|---|---|
| /s/ Joseph R Bronson | By: | /s/ John Stauss | |
| Joseph Bronson | John<br> Stauss, CEO | ||
| Date: | August<br> 14, 2024 | Date: | August<br> 14, 2024 |
EXHIBITA.
DESCRIPTIONOF SERVICES
Director shall have all responsibilities of a Director of the Company imposed by the state of Delaware or other applicable law, the Certificate of Incorporation, as amended, and Bylaws, as amended, of the Company. These responsibilities shall include, but shall not be limited to, the following:
1. Attendance. Use best efforts to attend scheduled meetings of Company’s Board of Directors.
2. Act as a Fiduciary. Represent the shareholders and the interests of Company as a fiduciary.
3. Participation. Participate as a full voting member of Company’s Board of Directors in setting overall objectives, approving plans and programs of operation, formulating general policies, offering advice and counsel, serving on Board Committees, and reviewing management performance.
4. Special Services. Director shall provide expertise relating to the effective development of products. Director shall introduce the Company to world class organizations that may be able to provide efficient solutions of issues that may arise relative to product engineering, product manufacturing, cost-efficient component acquisition, and other issues. Director shall also assist the Company to establish and/or secure an effective manufacturing facility/process for Company products.